34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 3 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by linearity 3 years
1. Laboratory Corp of America Holdings LH
80.3
2. Thermo Fisher Scientific TMO
54.58
3. Danaher DHR
47.32
4. Qiagen QGEN
34.63
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Agilent Technologies A
26.18
7. Sera Prognostics SERA
20.35
8. Quest Diagnostics DGX
19.79
9. Mettler-Toledo MTD
17.23
10. PerkinElmer PKI
16.14
11. Twist Bioscience TWST
13.9
12. IDEXX Laboratories IDXX
12.28
13. Anixa Biosciences ANIX
11.42
14. IQVIA Holdings IQV
11.05
15. DexCom DXCM
10.85
16. Syneos Health SYNH
10.68
17. Icon ICLR
10.29
18. Heska HSKA
7.67
19. MaxCyte MXCT
6.8
20. Olink Holding OLK
6.67
21. Exact Sciences EXAS
6.51
22. Waters WAT
6.5
23. Sotera Health SHC
5.04
24. NeoGenomics NEO
4.87
25. National Research NRC
4.36
26. Global Cord Blood CO
4.22
27. Bioventus BVS
4.21
28. Myriad Genetics MYGN
4
29. Charles River Laboratories CRL
3.76
30. CareDx CDNA
3.25
31. Guardant Health GH
3.13
32. Psychemedics PMD
2.74
33. Exagen XGN
2.66
34. Illumina ILMN
2.64
35. Pacific Biosciences of California PACB
2.64
36. Neogen NEOG
2.63
37. Fulgent Genetics FLGT
2.58
38. Enzo Biochem ENZ
2.57
39. Precipio PRPO
2.32
40. Personalis PSNL
2.28
41. Biodesix BDSX
2.28
42. MDxHealth MDXH
2.24
43. Medpace Holdings MEDP
2.02
44. Trinity Biotech TRIB
2
45. Neuronetics STIM
1.98
46. DarioHealth DRIO
1.79
47. Organovo Holdings ONVO
1.79
48. Inotiv NOTV
1.74
49. Co-Diagnostics CODX
1.7
50. Interpace Biosciences IDXG
1.68
51. bioAffinity Technologies BIAF
1.55
52. Prenetics Global PRE
1.54
53. SeqLL SQL
1.48
54. Aspira Womens Health AWH
1.38
55. Lantheus Holdings LNTH
1.23
56. RadNet RDNT
1.19
57. Meridian Bioscience VIVO
0.73
58. Natera NTRA
0.52
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.